CD57 MicroBeads, human

CD57 MicroBeads were developed for the positive selection or depletion of CD57+ cells from human PBMCs, body fluids, or single-cell suspensions from tissue (e.g. lymphoid tissues).

qualityAssuranceSatisfaction
guaranteed
more »
Specifications for CD57 MicroBeads, human
Overview

CD57 MicroBeads were developed for the positive selection or depletion of CD57+ cells from human PBMCs, body fluids, or single-cell suspensions from tissue (e.g. lymphoid tissues).

Detailed product information
Background information

The CD57 antigen, also known as HNK-1 or Leu-7, is an oligosaccharide antigenic moiety bound to surface proteins of certain cell types. CD57 is present on 15–20% of PBMCs, including subsets of NK cells and T cells and some neural cell types.1,2

CD57 has been shown to be expressed on late-stage CD8+ effector cells3 and terminally differentiated NK cells.

The frequency of CD57+ T lymphocytes is raised in a variety of diseases, for example, in rheumatoid arthritis4. Its expression is also increased on proliferation-incompentent or chronically activated CD8+ T cells in persistent viral infections, such as HIV.5

Columns

For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.

Product data and images for CD57 MicroBeads, human
Figure 1

CD57+ cells were isolated from human PBMCs using CD57 MicroBeads, an MS Column, and a MiniMACS™ Separator. Cells were stained with CD57-APC and analyzed by flow cytometry.

Resources for CD57 MicroBeads, human
Documents and Protocols
Citations for CD57 MicroBeads, human
Publications
  1. Mechtersheimer, G. et al. (1991) Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 51: 1300-1307
  2. Ong, E. et al. (2002) Biosynthesis of HNK-1 glycans on O-linked oligosaccharides attached to the neural cell adhesion molecule (NCAM): the requirement for core 2 β1,6-N-acetylglucosaminyltransferase and the muscle-specific domain in NCAM. J. Biol. Chem. 277: 18182-18190
  3. Dupuy d'Angeac, A. et al. (1993) Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 36: 608-612
  4. Brenchley, J. M. et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720
  5. Palmer, B. E. et al. (2005) Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175: 8415-8423

You have previously chosen International as your location.
What do you want to do?